• 1-phenyl-1H-pyrazolo[3,4-d]pyrimidin-4-amine for Src Assays

  2026-08-13

  PP 3 provides a matched negative-control strategy for separating Src-dependent effects from scaffold, vehicle, and pathway-independent responses in kinase and vascular assays. Its value is especially clear when PP2 reduces contraction or signaling but the mechanism must be tested against the L-type calcium-channel findings reported in neonatal arterial research.

• From FLCN Rescue to Translational RNA Design

  2026-08-12

  A mechanistic and strategic guide to using high-yield T7 transcription for FLCN mRNA rescue research. The article interprets recent Birt-Hogg-Dubé findings, translates them into experimental design principles, and explains how the HyperScribe™ T7 High Yield RNA Synthesis Kit Plus can support scalable, customizable RNA workflows while preserving appropriate boundaries between in vitro evidence and clinical translation.

• SB 431542 in Human Neuron Assays

  2026-08-12

  SB 431542 is a selective ALK5 inhibitor that can help resolve how TGF-β pathway activity shapes cell-state phenotypes. This article develops an assay-design framework linking Smad2 readouts with the recently validated human iPSC-derived sensory neuron model of HSV-1 latency, while clearly separating established evidence from exploratory application.

• Phosbind Biotin LC: PVDF Detection Guide

  2026-08-11

  Phosbind Biotin LC is a phosphate-binding reagent for sequence-independent detection of phosphorylated proteins on PVDF membranes when phospho-specific antibodies are unavailable or insufficient. It is intended for Western Blot workflows using streptavidin-HRP and chemiluminescence, and is not suitable for aqueous-only protocols or long-term storage of working solutions.

• Cell Senescence β-Galactosidase Staining Kit

  2026-08-10

  Learn how Cell Senescence β-Galactosidase Staining Kit, SKU K2185, supports practical SA-β-Gal detection when viability and proliferation assays produce ambiguous results. This scenario-based guide covers assay interpretation, polystyrene compatibility, protocol controls, data reporting, and vendor selection.

• Paroxetine Mesylate: SSRI Mechanism and Research Uses

  2026-08-09

  Paroxetine Mesylate is a Selective serotonin reuptake inhibitor with high-affinity SERT activity and reported secondary effects on CYP2D6, GRK2, MET, and ERBB3. Preclinical colorectal cancer findings and neurocardiac baboon data support distinct research applications, but neither establishes an oncology treatment or SUDEP-prevention indication.

• Dibutyryl-cAMP, Sodium Salt: Mechanism & Uses

  2026-08-08

  Dibutyryl-cAMP, sodium salt is a cell-permeable, stable cAMP analog used to elevate intracellular cAMP and examine PKA-dependent signaling. DBcAMP sodium salt supports cAMP signaling pathway research, but its PDE-inhibitory activity means that responses should not be interpreted as PKA-specific without appropriate controls.

• Nilotinib (AMN-107) Assay Guide

  2026-08-07

  A scenario-based guide to using Nilotinib (AMN-107), SKU A8232, in cell viability, proliferation, and cytotoxicity workflows. It connects BCR-ABL biology with practical decisions about model selection, solvent handling, dosing, endpoint interpretation, and supplier reliability.

• Baicalein: Mechanistic and Practical Guide for Cancer Resear

  2026-08-07

  Baicalein (5,6,7-trihydroxy-2-phenylchromen-4-one) is a high-purity flavonoid used to inhibit 12-lipoxygenase, modulate inflammation pathways, and study apoptosis in cancer research. Key facts include its molecular weight, solubility, and validated effects on cancer cell proliferation and enzyme regulation. This guide details its protocol parameters, mechanistic rationale, and research applications.

• Cyclophilin A Is Essential for Cyclosporine-Mediated Immunos

  2026-08-06

  This study demonstrates that cyclophilin A is the indispensable intracellular target required for cyclosporine's immunosuppressive effect. Using cyclophilin A-deficient mice, the authors show resistance to cyclosporine, refining mechanistic understanding for transplantation immunology and informing future research on calcineurin inhibitor specificity.

• Vorinostat (SAHA): Strategic Epigenetic Modulation in Oncolo

  2026-08-06

  This thought-leadership article synthesizes mechanistic insight and translational guidance for researchers leveraging Vorinostat (suberoylanilide hydroxamic acid) in cancer biology. Bridging foundational epigenetic biology, advanced apoptosis assays, and emerging cross-talk with non-transcriptional regulation, the article contextualizes Vorinostat’s unique position within the evolving landscape of oncology research. Citing pivotal studies and integrating recent breakthroughs in real-time enzyme activity imaging, it offers actionable recommendations and forward-looking strategies for next-generation experimental design.

• METTL17 Regulates Ferroptosis and Tumorigenesis in Colorecta

  2026-08-05

  The referenced study reveals that the mitochondrial protein METTL17 confers resistance to ferroptosis and promotes tumorigenesis in colorectal cancer by regulating mitochondrial RNA methylation and translation. These findings highlight METTL17 as a promising target to sensitize tumors to ferroptosis-based therapies, providing a mechanistic link between mitochondrial function and cancer cell survival.

• Parathyroid hormone (1-34) (human): Precision in Bone and Ki

  2026-08-05

  Parathyroid hormone (1-34) (human) from APExBIO brings unmatched mechanistic accuracy to bone metabolism and kidney disease research models. This article delivers actionable protocols, advanced troubleshooting, and a translational bridge to recent discoveries in valvular calcification and endothelial biology.

• G-15: G Protein-Coupled Estrogen Receptor Antagonist in Rese

  2026-08-04

  G-15 enables precise, selective inhibition of GPR30, empowering researchers to dissect non-genomic estrogen signaling in immune, neuro, and cancer models. Its robust solubility in DMSO and high specificity streamline advanced workflows, while data-backed protocols ensure reproducibility and minimal off-target effects.

• Firefly Luciferase mRNA: Optimizing Bioluminescent Assays

  2026-08-04

  Firefly Luciferase mRNA (ARCA, 5mCTP, ΨUTP) delivers unprecedented control and sensitivity for gene expression, viability, and in vivo imaging workflows. This guide details experimental strategies, advanced delivery innovations, and troubleshooting tactics to maximize reproducibility and signal strength.

449 records 8/30 page Previous Next First page 上5页 678910 下5页 Last page